Accessibility Menu
Arrow-Thin-Down
S&P 500
6,738.44
+0.6%
+39.04
Arrow-Thin-Down
DJI
46,734.61
+0.3%
+144.20
Arrow-Thin-Down
NASDAQ
22,941.80
+0.9%
+201.40
Arrow-Thin-Down
Bitcoin
$111,317
+2.3%
+$2,554.83
Arrow-Thin-Down
AAPL
$259.44
+0.4%
+$0.99
Arrow-Thin-Down
AMZN
$221.02
+1.4%
+$3.07
Arrow-Thin-Down
GOOG
$253.73
+0.5%
+$1.2
Arrow-Thin-Down
META
$734.15
+0.1%
+$0.74
Arrow-Thin-Down
MSFT
$520.56
+0.0%
+$0.02
Arrow-Thin-Down
NVDA
$182.2
+1.1%
+$1.92
Arrow-Thin-Down
TSLA
$448.98
+2.3%
+$10.01
Daily Stock GainersDaily Stock LosersMost Active Stocks

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price
$0.00
Daily Change
(-) $0.00
Day's Range
$0.00 - $0.00
Previous Close
$0.00
Open
$0.00
Beta
0
Volume
-
Average Volume
-
Sector
Health Care
Market Cap
-
Market Cap / Employee
-
52wk Range
$0.00 - $0.00
Revenue
-
Gross Margin
-
Dividend Yield
-
EPS
$0.00
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

2seventy Bio Company Info

2seventy Bio, Inc. operates as cell and gene therapy company. It is focused on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.

News & Analysis

Featured Article

2seventy Bio's Losses Narrow, Sales Dip

2seventy Bio notably reduced operating expenses in the third quarter, but revenue challenges persisted.

Motley Fool Markets Team  |  Nov 12, 2024

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services